Lewis JS - Search Results

1

Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.

Lewis JS, Lewis MR, Cutler PD, Srinivasan A, Schmidt MA, Schwarz SW, Morris MM, Miller JP, Anderson CJ. Lewis JS, et al. Among authors: lewis mr. Clin Cancer Res. 1999 Nov;5(11):3608-16. Clin Cancer Res. 1999. PMID: 10589778

2

Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats.

Anderson CJ, Jones LA, Bass LA, Sherman EL, McCarthy DW, Cutler PD, Lanahan MV, Cristel ME, Lewis JS, Schwarz SW. Anderson CJ, et al. Among authors: lewis js. J Nucl Med. 1998 Nov;39(11):1944-51. J Nucl Med. 1998. PMID: 9829587 Free article.

3

Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.

Lewis JS, McCarthy DW, McCarthy TJ, Fujibayashi Y, Welch MJ. Lewis JS, et al. J Nucl Med. 1999 Jan;40(1):177-83. J Nucl Med. 1999. PMID: 9935074 Free article.

4

Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.

Lewis JS, Lewis MR, Srinivasan A, Schmidt MA, Wang J, Anderson CJ. Lewis JS, et al. Among authors: lewis mr. J Med Chem. 1999 Apr 22;42(8):1341-7. doi: 10.1021/jm980602h. J Med Chem. 1999. PMID: 10212119

5

In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.

Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ. Lewis JS, et al. Nucl Med Biol. 1999 Apr;26(3):267-73. doi: 10.1016/s0969-8051(98)00105-x. Nucl Med Biol. 1999. PMID: 10363797

6

High purity production and potential applications of copper-60 and copper-61.

McCarthy DW, Bass LA, Cutler PD, Shefer RE, Klinkowstein RE, Herrero P, Lewis JS, Cutler CS, Anderson CJ, Welch MJ. McCarthy DW, et al. Among authors: lewis js. Nucl Med Biol. 1999 May;26(4):351-8. doi: 10.1016/s0969-8051(98)00113-9. Nucl Med Biol. 1999. PMID: 10382836

7

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

Lewis J, Laforest R, Buettner T, Song S, Fujibayashi Y, Connett J, Welch M. Lewis J, et al. Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1206-11. doi: 10.1073/pnas.98.3.1206. Proc Natl Acad Sci U S A. 2001. PMID: 11158618 Free PMC article.

8

Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model.

Lewis JS, Laforest R, Lewis MR, Anderson CJ. Lewis JS, et al. Among authors: lewis mr. Cancer Biother Radiopharm. 2000 Dec;15(6):593-604. doi: 10.1089/cbr.2000.15.593. Cancer Biother Radiopharm. 2000. PMID: 11190491

9

64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

Anderson CJ, Dehdashti F, Cutler PD, Schwarz SW, Laforest R, Bass LA, Lewis JS, McCarthy DW. Anderson CJ, et al. Among authors: lewis js. J Nucl Med. 2001 Feb;42(2):213-21. J Nucl Med. 2001. PMID: 11216519 Free article.

10

Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model.

Lewis JS, Wang M, Laforest R, Wang F, Erion JL, Bugaj JE, Srinivasan A, Anderson CJ. Lewis JS, et al. Int J Cancer. 2001 Dec 15;94(6):873-7. doi: 10.1002/ijc.1540. Int J Cancer. 2001. PMID: 11745491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,013 results

Search Page

Filters